Using the patch-clamp technique, we examined whole cell Ca V currents of pericytes that contract descending vasa recta (DVR). The dihydropyridine Ca V agonist FPL64176 (FPL) stimulated inward Ca 2ϩ and Ba 2ϩ currents that activated with threshold depolarizations to Ϫ40 mV and maximized between Ϫ20 and Ϫ10 mV. These currents were blocked by nifedipine (1 M) and Ni 2ϩ (100 and 1,000 M), exhibited slow inactivation, and conducted Ba 2ϩ Ͼ Ca 2ϩ at a ratio of 2.3:1, consistent with "long-lasting" L-type Ca V. In FPL, with 1 mM Ca 2ϩ as charge carrier, Boltzmann fits yielded half-maximal activation potential (V 1/2) and slope factors of Ϫ57.9 mV and 11.0 for inactivation and Ϫ33.3 mV and 4.4 for activation. In the absence of FPL stimulation, higher concentrations of divalent charge carriers were needed to measure basal currents. In 10 mM Ba 2ϩ , pericyte CaV currents activated with threshold depolarizations to Ϫ30 mV, were blocked by nifedipine, exhibited voltage-dependent block by diltiazem (10 M), and conducted Ba 2ϩ Ͼ Ca 2ϩ at a ratio of ϳ2:1. In Ca 2ϩ , Boltzmann fits to the data yielded V1/2 and slope factors of Ϫ39.6 mV and 10.0 for inactivation and 2.8 mV and 7.7 for activation. In Ba 2ϩ , V1/2 and slope factors were Ϫ29.2 mV and 9.2 for inactivation and Ϫ5.6 mV and 6.1 for activation. Neither calciseptine (10 nM), mibefradil (1 M), nor -agatoxin IVA (20 and 100 nM) blocked basal Ba 2ϩ currents. Calciseptine (10 nM) and mibefradil (1 M) also failed to reverse ANG II-induced DVR vasoconstriction, although raising mibefradil concentration to 10 M was partially effective. We conclude that DVR pericytes predominantly express voltage-gated divalent currents that are carried by L-type channels. barium; calcium; ion channel; mibefradil; patch clamp WITHIN THE OUTER STRIPE of the outer medulla, juxtamedullary efferent arterioles divide to form descending vasa recta (DVR), which supply blood flow to the renal medulla. An increasing body of evidence has shown that voltage-gated Ca 2ϩ channels (Ca V ) play an important role in the regulation of basal tone and agonist-induced contraction of the juxtamedullary efferent circulation (13-15, 22, 31). Consistent with this evidence, Ca 2ϩ channel blockers (CCB) have been observed to enhance medullary perfusion (1, 8, 16, 19, 20, 36, 55) . The relative roles of DVR vs. upstream juxtamedullary vascular segments in the actions of CCB cannot be easily discerned, because the overlying renal cortex prevents access in vivo. Cell culture models that replicate the behavior of the pericytes and endothelia that comprise the DVR wall are lacking. To permit ex vivo investigations, DVR have been explanted for microperfusion, microfluorescence, and patch-clamp studies (42, 44, 45) , and behavior consistent with Ca V -mediated regulation has been observed. ANG II, endothelin-1, and vasopressin depolarize DVR pericytes through a variable combination of Ca 2ϩ -dependent Cl Ϫ channel activation and K ϩ channel suppression (4, 43, 44, 59 (32, 58). Motivated by the above-described evidence, functional expression of Ca V in juxtamedullary efferent arterioles, and immunochemical evidence favoring their presence in DVR pericytes (21, 22, 31), we performed the present study to measure their signature currents. In series 1, we found that the dihydropyridine agonist FPL64176 (FPL) readily stimulates inward Ca 2ϩ and Ba 2ϩ currents, the characteristics of which are consistent with L-type channels. In the absence of FPL stimulation, otherwise small basal Ca V currents were readily measured when intracellular Ca 2ϩ was chelated and extracellular concentrations of Ca 2ϩ or Ba 2ϩ were raised to carry charge. Those basal Ca V currents were blocked by nifedipine, Ni 2ϩ , and diltiazem, but not calciseptine, -agatoxin IVA, or low concentrations of mibefradil. Kinetics, activation and inactivation thresholds, and the ratio of Ba 2ϩ to Ca 2ϩ conductance are consistent with the predominance of L-type channels. We conclude that the channel architecture of explanted DVR pericytes most closely resembles that described for afferent smooth muscle, where Cl Ϫ channel activity and L-type Ca V control membrane potential and Ca 2ϩ entry, respectively (2, 5, 18, 29) .
Using the patch-clamp technique, we examined whole cell Ca V currents of pericytes that contract descending vasa recta (DVR). The dihydropyridine Ca V agonist FPL64176 (FPL) stimulated inward Ca 2ϩ and Ba 2ϩ currents that activated with threshold depolarizations to Ϫ40 mV and maximized between Ϫ20 and Ϫ10 mV. These currents were blocked by nifedipine (1 M) and Ni 2ϩ (100 and 1,000 M), exhibited slow inactivation, and conducted Ba 2ϩ Ͼ Ca 2ϩ at a ratio of 2.3:1, consistent with "long-lasting" L-type Ca V. In FPL, with 1 mM Ca 2ϩ as charge carrier, Boltzmann fits yielded half-maximal activation potential (V 1/2) and slope factors of Ϫ57.9 mV and 11.0 for inactivation and Ϫ33.3 mV and 4.4 for activation. In the absence of FPL stimulation, higher concentrations of divalent charge carriers were needed to measure basal currents. In 10 mM Ba 2ϩ , pericyte CaV currents activated with threshold depolarizations to Ϫ30 mV, were blocked by nifedipine, exhibited voltage-dependent block by diltiazem (10 M), and conducted Ba 2ϩ Ͼ Ca 2ϩ at a ratio of ϳ2:1. In Ca 2ϩ , Boltzmann fits to the data yielded V1/2 and slope factors of Ϫ39.6 mV and 10.0 for inactivation and 2.8 mV and 7.7 for activation. In Ba 2ϩ , V1/2 and slope factors were Ϫ29.2 mV and 9.2 for inactivation and Ϫ5.6 mV and 6.1 for activation. Neither calciseptine (10 nM), mibefradil (1 M), nor -agatoxin IVA (20 and 100 nM) blocked basal Ba 2ϩ currents. Calciseptine (10 nM) and mibefradil (1 M) also failed to reverse ANG II-induced DVR vasoconstriction, although raising mibefradil concentration to 10 M was partially effective. We conclude that DVR pericytes predominantly express voltage-gated divalent currents that are carried by L-type channels. barium; calcium; ion channel; mibefradil; patch clamp WITHIN THE OUTER STRIPE of the outer medulla, juxtamedullary efferent arterioles divide to form descending vasa recta (DVR), which supply blood flow to the renal medulla. An increasing body of evidence has shown that voltage-gated Ca 2ϩ channels (Ca V ) play an important role in the regulation of basal tone and agonist-induced contraction of the juxtamedullary efferent circulation (13-15, 22, 31) . Consistent with this evidence, Ca 2ϩ channel blockers (CCB) have been observed to enhance medullary perfusion (1, 8, 16, 19, 20, 36, 55) . The relative roles of DVR vs. upstream juxtamedullary vascular segments in the actions of CCB cannot be easily discerned, because the overlying renal cortex prevents access in vivo. Cell culture models that replicate the behavior of the pericytes and endothelia that comprise the DVR wall are lacking. To permit ex vivo investigations, DVR have been explanted for microperfusion, microfluorescence, and patch-clamp studies (42, 44, 45) , and behavior consistent with Ca V -mediated regulation has been observed. ANG II, endothelin-1, and vasopressin depolarize DVR pericytes through a variable combination of Ca 2ϩ -dependent Cl Ϫ channel activation and K ϩ channel suppression (4, 43, 44, 59 (32, 58) . Motivated by the above-described evidence, functional expression of Ca V in juxtamedullary efferent arterioles, and immunochemical evidence favoring their presence in DVR pericytes (21, 22, 31) , we performed the present study to measure their signature currents. In series 1, we found that the dihydropyridine agonist FPL64176 (FPL) readily stimulates inward Ca 2ϩ and Ba 2ϩ currents, the characteristics of which are consistent with L-type channels. In the absence of FPL stimulation, otherwise small basal Ca V currents were readily measured when intracellular Ca 2ϩ was chelated and extracellular concentrations of Ca 2ϩ or Ba 2ϩ were raised to carry charge. Those basal Ca V currents were blocked by nifedipine, Ni 2ϩ , and diltiazem, but not calciseptine, -agatoxin IVA, or low concentrations of mibefradil. Kinetics, activation and inactivation thresholds, and the ratio of Ba 2ϩ to Ca 2ϩ conductance are consistent with the predominance of L-type channels. We conclude that the channel architecture of explanted DVR pericytes most closely resembles that described for afferent smooth muscle, where Cl Ϫ channel activity and L-type Ca V control membrane potential and Ca 2ϩ entry, respectively (2, 5, 18, 29) .
METHODS

Isolation of DVR.
Investigations involving animal use were performed according to protocols approved by the Institutional Animal Use and Care Committee of the University of Maryland. Rats were anesthetized by an intraperitoneal injection of ketamine (80 mg/kg) and xylazine (10 mg/kg). Under full anesthesia, the abdomen was opened and the kidneys were excised, so that euthanasia was induced by concomitant exsanguination. Tissue slices were stored at 4°C in a physiological saline solution (in mM: 155 NaCl, 5 KCl, 1 MgCl 2, 1 CaCl 2, 10 HEPES, and 10 glucose, pH 7.4). As described previously (44), for patch-clamp studies, small wedges of renal medulla were dissected and transferred to Blendzyme 1 (Roche) at 0.27 mg/ml in high-glucose DMEM (Invitrogen, without serum), incubated at 37°C for 20 min, transferred to physiological saline solution, and stored at 4°C. Enzymatic tissue digestion was omitted when DVR were explanted for microperfusion (42) .
Whole cell patch-clamp recording. Gigaseals were directly formed on abluminal pericytes of isolated vessels as previously described (44, 48, 57) and studied by ruptured-patch whole cell recording (58 (58) . Results were corrected for junction potentials as previously described (37, 44) . The cell capacitance observed in these studies [13.6 Ϯ 0.5 pF (SE), n ϭ 78] is similar to that previously observed (12.2 Ϯ 0.5 pF, n ϭ 94) in rat pericytes during study of voltage-gated Na ϩ currents (58) . Vasoactivity measurements. Vasoactivity was studied by videomicroscopy using isolated, microperfused DVR (42) . This preparation requires vessels to be explanted without enzymatic digestion, so that their walls withstand transmural pressure without rupturing. Isolated DVR were mounted on concentric pipettes, cannulated at one end, and held at the other end to permit flow into the collection pipette. The pipettes and vessels were positioned with micromanipulators (Instruments Technology and Machinery, Schertz, TX) near a thermocouple in the narrow entrance region of a custom-built chamber. Temperature was maintained with a feedback system (CN9000A, Omega Engineering, Bridgeport, NJ) at 37°C. The buffer used for dissection, perfusion, and bath was the same as that previously employed for similar experiments: 140 mM NaCl, 10 mM Na acetate, 5 mM KCl, 1.2 mM MgCl 2, 2 mM NaHPO4/NaH2PO4, 1 mM CaCl2, 5 mM alanine, 0.1 mM L-arginine, 5 mM glucose, 5 mM HEPES, and 0.5 g/dl albumin, pH 7.4 at 37°C (41) . DVR were observed through a ϫ40 objective to yield the final magnification of ϫ1,300, and images were captured with a Spot camera (Diagnostic Instruments). As in prior studies, constriction was quantified as percent reduction of internal diameter at the point of maximal constriction using National Institutes of Health ImageJ software for offline analysis (4, 41, 59 Reagents. FPL and TTX were obtained from Tocris-Cookson (Ellisville, MO); calciseptine and -agatoxin IVA from Alomone (Jerusalem, Israel); Blendzyme 1 from Roche Applied Science (Indianapolis, IN); and ANG II, NiCl 2, niflumic acid, mibefradil, nifedipine, diltiazem, and other chemicals from Sigma. Nifedipine, FPL, and niflumic acid were dissolved in DMSO. TTX was dissolved in aqueous 10 mM Na acetate buffer, pH 4.5. ANG II, mibefradil, and NiCl 2 were dissolved in water. Reagents were stored frozen at Ϫ20°C, thawed, and diluted 1:1,000 on the day of the experiment. Excess reagents were discarded daily. Blendzyme was stored in 40-l aliquots of 4.5 mg/ml in water and diluted into high-glucose DMEM on the day of the experiment.
Statistics. Curve fits were performed with Clampfit 9.2 (Axon Instruments) using Levenberg-Marquardt algorithms. Values are means Ϯ SE. The significance of differences was evaluated with SigmaStat 3.11 (Systat Software, Point Richmond, CA) using parametric or nonparametric tests as appropriate for the data. Comparisons between two groups were performed with Student's t-test (paired or unpaired, as appropriate) or the rank sum test (nonparametric). Comparisons between multiple groups employed one-way ANOVA, repeated-measures ANOVA, or repeated-measures ANOVA on ranks (nonparametric). P Ͻ 0.05 was used to reject the null hypothesis.
RESULTS
L-type Ca V currents stimulated by FPL.
In the first series of experiments, we repeatedly depolarized pericytes from a holding level of Ϫ100 to 0 mV at 10-s intervals. Basal and FPL-stimulated currents were measured with EGTA as the Ca 2ϩ chelator in the electrode and 1 mM Ca 2ϩ as the extracellular charge carrier. As shown in Fig. 1 , Aa and Ab, basal (no FPL) inward currents were nearly undetectable under these conditions. In contrast, when FPL was added to the extracellular buffer in sequentially increasing concentrations (0.1, 1.0, and 10 M), a slowly inactivating inward current emerged when the cells were depolarized.
Voltage-dependent characteristics of the FPL (10 M)-stimulated current were further studied using the protocol shown in the inset of Fig. 1Ba and are summarized in Fig. 1Bb . Basal inward current magnitude was Ͻ10 pA. In contrast, in FPL they activated at a threshold depolarization of about Ϫ40 mV, maximized between Ϫ10 and 0 mV, and reached ϳ35 pA.
To study characteristics of inactivation of the FPL-induced current, the protocol illustrated in Fig. 2Aa (example in Fig.  2Ab ) was executed. Pericytes were held at Ϫ110 to Ϫ10 mV for 1,000 ms and then depolarized to Ϫ10 mV. A summary of the voltage dependence of inactivation (I Ca /I Ca,max , where I Ca is Ca 2ϩ current) and activation (g/g max , where g is conductance) is superimposed in Fig. 2B upon corresponding fits to the Boltzmann equation:
where V m is membrane potential, s ϭ Ϫ1 or ϩ1 for activation or inactivation, respectively, and V 1/2 and K (slope factor) are constants. Activation was computed from the Ca 2ϩ chord conductance (g), where g ϭ I Ca /(V m Ϫ Ca rev ) and Ca rev is the reversal potential. Values were normalized to maximum conductance (g max ). Inactivation of the FPL current commenced between Ϫ80 and Ϫ90 mV with V 1/2 of Ϫ57.9 mV and slope factor of 11.0. Activation occurred between Ϫ30 and Ϫ40 mV with V 1/2 of Ϫ33.3 mV and slope factor of 4.4, yielding an overlapping window current between Ϫ50 and Ϫ10 mV.
Blockade of FPL current with nifedipine and Ni 2ϩ . The FPL-stimulated inward current was sensitive to nifedipine (1 M; Fig. 3 ) and Ni 2ϩ (Fig. 4) . Representative traces are provided in Fig. 3Aa , where, at baseline, only a rapidly inactivating "fast" inward Na ϩ current is present (58) . Subsequently, FPL (10 M) was introduced to elicit the slowly inactivating component of inward current. This was followed by addition and washout of nifedipine. In similar experiments without FPL, nifedipine failed to affect basal current (Fig.  3Ab) . In contrast, it reversibly blocked the FPL-stimulated current (Fig. 3Ac) over the entire range of depolarization potentials (V m ; Fig. 3B ). We also tested the effectiveness of Fig. 2 . Voltage dependence of inactivation and activation of FPL-stimulated ICa. Aa: protocol used to study inactivation. Pericytes were held at various potentials (Vhold) for 1,000 ms and then depolarized to Ϫ10 mV. Ab: effects of various holding potentials on ICa. B: inactivation (ICa/ICa,max, n ϭ 16) and activation [g/gmax (where g is conductance), n ϭ 9] characteristics with 1 mM extracellular Ca 2ϩ and 10 mM FPL as agonist. Half-maximal activation poential (V1/2) and slope factor (K) for Boltzmann fits were Ϫ57.9 mV and 11.0 for inactivation and Ϫ33.3 mV and 4.4 for activation, respectively. . At baseline, Ni 2ϩ (1,000 M) blocked a very small, depolarization-induced inward current (Fig. 4B) . Between 100 and 1,000 M, Ni 2ϩ potently and reversibly inhibited the FPL-stimulated inward currents (Fig. 4C) . (51, 56) . To increase overall inward current to examine that characteristic, we increased the concentration of divalent charge carriers to 10 mM. As shown in Fig. 5A , large FPL-stimulated Ba 2ϩ currents (peak Ϫ399 pA at Ϫ20 mV) exceeded Ca 2ϩ currents (peak Ϫ251 pA at Ϫ10 mV). In a separate series of experiments, we repetitively depolarized individual cells from Ϫ110 to Ϫ10 mV and exchanged extracellular buffer to contain Ca 2ϩ or Ba 2ϩ (10 mM) in random order to yield a more rigorous paired comparison of their conductances. Mean currents for Ba 2ϩ and Ca 2ϩ in FPL were Ϫ378 Ϯ 31 and Ϫ165 Ϯ 21 pA (P Ͻ 0.01), respectively (Fig. 5B) .
Since unstimulated Ca V currents in 1 mM Ca 2ϩ are too small to study (Fig. 1) , we further optimized our conditions for measurement of basal currents by substituting BAPTA (10 mM) for EGTA to rapidly chelate Ca 2ϩ , thereby reducing any Ca 2ϩ -dependent inhibition (46) . Moreover, we maintained extracellular concentrations of Ca 2ϩ and Ba 2ϩ at 10 mM (rather than 1 mM) to increase whole cell current and included TTX in the extracellular buffer to prevent the fast voltage-gated Na ϩ current from contaminating any rapidly inactivating T-type currents that might exist. Under those conditions, the basal inward currents were large enough to be measured without use of FPL as an agonist. Where seals were stable, activation and inactivation characteristics for Ba 2ϩ and Ca 2ϩ (Fig. 6 ) were examined in random order in the same cells. As shown in Fig.  6A , between test potentials of Ϫ10 and 20 mV, basal Ba 2ϩ currents consistently exceeded those of Ca 2ϩ by Ͼ2. Both activated at a threshold of about Ϫ30 mV, a somewhat higher potential than observed in FPL (Ϫ50 to Ϫ40 mV; Fig. 5A ). These collective findings are consistent with predominance of L-type Ca V basal conductance under these experimental conditions. Examination of the voltage dependence of inactivation of basal currents by use of a protocol similar to that used in Fig.  2Aa reinforced this relationship (Fig. 6B ) and yielded the Boltzmann fits illustrated in Fig. 6 , Ca and Cb. Window currents for both divalent ions are between Ϫ40 and ϩ10 mV.
Sensitivity of pericyte Ba 2ϩ currents to L-type channel blockade. Using the same electrode buffer (BAPTA) and 10 mM Ba 2ϩ as charge carrier, we explored the sensitivity of the basal pericyte inward currents to the classical L-type CCB nifedipine and diltiazem. As shown in Fig. 7A , nifedipine (1 M) was highly effective in eliminating the Ba 2ϩ currents. . IBa exceeded ICa, and its activation threshold was shifted toward more negative potentials. n ϭ 9 and 12 for IBa and ICa, respectively. *P Ͻ 0.05, IBa vs. ICa. B: paired comparison of IBa and ICa in FPL (10 M) and extracellular Ca 2ϩ or Ba 2ϩ (10 mM) exchanged into the bath in random order. n ϭ 10. **P Ͻ 0.01, IBa vs. ICa. Diltiazem (10 M) was also effective but exhibited voltage dependence; it was ineffective when cells were held at Ϫ90 mV (Fig. 7Ba) but highly effective when the holding potential was raised to Ϫ40 mV (Fig. 7Bb) . This suggests improvement of access of diltiazem to its binding site with increases in membrane potential (53) . The effectiveness of diltiazem in Fig.  7B is consistent with our previous observation that it blocks ANG II-induced vasoconstriction and KCl-induced pericyte [Ca] CYT elevation (61) .
In view of the exquisite sensitivity of inhibition of rabbit afferent arteriolar KCl constriction to the black mamba toxin calciseptine (EC 50 ϭ 80 fM) (22), we also examined its ability to block Ba 2ϩ currents in DVR pericytes. Surprisingly, at a 10 5 -fold greater concentration (10 nM), it affected neither basal nor FPL-stimulated Ba 2ϩ current (Fig. 8, A and B) . Similarly, at the higher concentration of 30 nM, it failed to reverse ANG II (1 nM)-induced contraction of microperfused vessels (Fig. 8C) .
Sensitivity of pericyte Ba 2ϩ currents to mibefradil. Given the growing literature concerning the role of T-type channels in the efferent circulation of the kidney (13, 22, 24, 26, 27 , 31), we tested the ability of mibefradil to block DVR pericyte Ba 2ϩ currents and vasoconstriction. Perfectly selective T-type Ca V blockers do not exist; however, it is generally accepted that mibefradil inhibits T-type over L-type Ca V when it is used at low concentrations, between 10 and 1,000 nM, which blocked efferent arteriolar constriction in other settings (13, 22, 25, 28, 31) . In our hands, mibefradil (1 M) affected neither Ba 2ϩ currents nor ANG II-induced DVR vasoconstriction (Fig. 9, A and B) . At higher concentration (10 M), where mibefradil is likely to block L-and T-type Ca V , it was an effective vasodilator (Fig. 9B) .
Sensitivity of pericyte Ba 2ϩ currents to -agatoxin IVA. Expression of Ca V 2.x in DVR pericytes has been observed by immunostaining, and the P/Q-type Ca V inhibitor -agatoxin IVA (10 nM) is a potent blocker of afferent arteriolar constriction to KCl in the rabbit (2, 21). Since the Ba 2ϩ Ͼ Ca 2ϩ current and slow inactivation observed above might hypothetically contain a component of P/Q-type Ca V conductance, we tested whether -agatoxin IVA provides any blockade. At Յ100 nM, -agatoxin IVA was ineffective (Fig. 10) .
DISCUSSION
Ca 2ϩ influx through Ca V facilitates elevation of [Ca] CYT during myocyte contraction. Ca V are the product of 10 genes, the splice variants of which form the pore-forming ␣ 1a -to ␣ 1l -subunits of the channels. When combined with ␣ 2 -, ␤-, and ␦-subunits, they yield an array of properties characterized by variable kinetic behavior, voltage dependence, and sensitivity to toxins and pharmaceuticals (7, 11, 12, 27, 28, 31, 33, 38, 40, 52, 54, 56) . Many Ca V classification schemes exist. One durable approach has been to designate them L-type (Ca V 1.x), T-type (Ca V 2.x), P/Q-type (Ca V 2.1), N-type (Ca V 2.2), and R-type (Ca V 2.3). L-type Ca V , so designated to describe their long opening and slow rate of inactivation, are common therapeutic targets in the treatment of hypertension, angina, and arrhythmias via dihydropyridine (e.g., nifedipine), phenylalkylamine (verapamil), and benzothiazepine (diltiazem) antagonists. T-type Ca V , so designated to describe their transient opening and rapid inactivation, are also widely expressed in the cardiovascular system and have become a therapeutic target of less selective antagonists, such as mibefradil, pimozide, and efonidipine, that block L-and T-type channels (27, 28, 38, 40, 56) . That therapeutic class may provide additive antihypertensive efficacy, because T-type channels are expressed in smooth muscle of small-resistance vessels (3) .
The actions of CCB in the renal circulation have been intensively investigated, and the results point to heterogeneity of expression and action in the cortex and medulla. CCB classes vary in their ability to reverse contraction of and Ca 2ϩ entry into vascular smooth muscle of the glomerular afferent and efferent arteriole. Evidence also has shown that their efficacy to block efferent contraction may vary with location of the vessel in the superficial vs. juxtamedullary cortex (21, 22, 27, 31) .
Despite reducing the electrochemical driving force for Ca 2ϩ entry, membrane depolarization increases [Ca] CYT of smooth muscle by gating Ca V conductance. To achieve depolarization without use of vasoactive agonists, a popular maneuver has been to raise the Nernst potential of K ϩ from Ϫ90 to ϳ0 mV by increasing its extracellular concentration. The ability of CCB to prevent the resultant contraction and rise in [Ca] CYT is interpreted as evidence for Ca V expression. In the hydronephrotic kidney preparation, KCl caused nifedipine-sensitive constriction of afferent arterioles that exceeded constriction of the efferent arteriole (35) . Similarly, diltiazem preferentially blocked KCl-induced vasoconstriction of isolated perfused afferent arterioles (9 (6) .
Blockade of responsiveness to agonists such as ANG II has provided an alternate means to assess participation of Ca V in intrarenal microvessel contraction. When ANG II-stimulated Ca 2ϩ entry into interlobular and afferent arteriolar smooth muscle was examined using fura 2, it was found that ANG II-induced increases in [Ca] CYT were dihydropyridine sensitive (30) . Parallel studies found greater sensitivity of ANG IIstimulated [Ca] CYT increases to nifedipine in the afferent than efferent arteriole (34) . L-type signature currents have been elegantly described by electrophysiology in myocytes of the afferent circulation (2, 18) . These and other studies have consistently established that L-type voltage-gated channels provide a functionally important route for Ca 2ϩ entry into preglomerular smooth muscle.
More recent investigations have expanded the known roles of Ca V in the kidney by documenting multiple subtype expression and the variable efficacy of pharmacological blockade in the afferent and efferent circulation. In particular, Hansen and colleagues (21, 22) described L-, T-, and P/Q-type channel expression in afferent smooth muscle, as well as both T-and L-type channel expression in efferent arterioles. Efferent Ca V expression was confined to the juxtamedullary cortex. Those immunochemical observations were reinforced by demonstration of sensitivity of KCl-induced efferent contraction to blockade with calciseptine (an L-type channel antagonist) and mibefradil (a T-type channel blocker) (2, 21, 22, 31). Feng and colleagues (13) (14) (15) used the juxtamedullary nephron preparation to examine the roles of arteriolar Ca V . Pimozide and mibefradil (T-type channel blockers) reduced basal tone of afferent and efferent arterioles. In contrast, successful blockade with diltiazem (L-type channel blocker) occurred only in afferent arterioles, except when generation of nitric oxide was prevented by nitric oxide synthase inhibition. In their hands, T-type channel blockade with pimozide reversed afferent and efferent contraction by ANG II (13) (14) (15) . Elegant studies in the renal cortex, performed in vivo using a pencil lens camera, also documented that efferent arterioles are dilated by nonselective CCB, such as efonidipine and mibefradil (28) . Taken together, a role for Ca V , particularly T-type channels, in myogenic tone and agonist-induced contraction of juxtamedullary efferent arterioles is well supported, and the ability of combined T-and L-type channel blockade to provide renoprotection through efferent dilation has thus become the subject of clinical investigation (23, 49, 50) .
Investigation of the role of Ca V in the microcirculation of the medulla has lagged behind that of the cortex. Interstitial infusion of diltiazem and intravenous infusion of verapamil selectively raised medullary blood flow (19, 20, 36) . Using singlevessel videomicroscopy, Yagil and colleagues (55) observed an increase in papillary vasa recta blood flow by the dihydropyridine blocker CS-905. The effects of CCB on medullary blood flow have also been examined in pathological models. Papillary plasma flow increased when verapamil was infused into the renal artery of dogs subjected to caval constriction (8) . Treatment of the spontaneously hypertensive rat with nisoldipine enhanced medullary blood flow and Na ϩ excretion (16) . Taken together, the ability of L-type CCB to increase renal medullary blood flow has been a consistent finding. DVR are contractile branches of the juxtamedullary cortical circulation; Fig. 7 . Inhibition of IBa by nifedipine and diltiazem. A: peak IBa in pericytes held at Ϫ90 mV and depolarized to test potentials (Vm) in 10 mM Ba 2ϩ . Inward currents are at baseline, in nifedipine (1 M), and after washout. n ϭ 8. *P Ͻ 0.05, baseline vs. nifedipine. B: peak IBa in pericytes held at Ϫ90 mV and depolarized to test potentials in 10 mM Ba 2ϩ at baseline, in diltiazem (10 M), and after washout (n ϭ 5). C: peak IBa in pericytes held at Ϫ40 mV and depolarized to test potentials in 10 mM Ba 2ϩ at baseline, in diltiazem, and after washout. n ϭ 5. *P Ͻ 0.05, baseline vs. diltiazem. therefore, it is uncertain whether the effects of L-type channel blockade are attributable to DVR vs. upstream segments.
Because of the relative inaccessibility of outer medullary DVR in vivo, their properties have been studied in isolated vessels (41, 42) or tissue preparations (10) . The first evidence favoring participation of Ca V in vasa recta was the consistency of ANG II-induced pericyte depolarization (44) and the ability of L-type blockade with diltiazem to vasodilate preconstricted vessels and block [Ca] CYT responses to ANG II, KCl, and PKC activation (60, 61) . Robust ability of vasoactive agonists to depolarize pericytes through variable combination of Ca 2ϩ -dependent Cl Ϫ channel activation and K ϩ channel suppression has been a consistent finding (4, 43, 44) . Motivated by the associated studies that clearly show Ca V in juxtamedullary Fig. 8 . Lack of effect of calciseptine to reverse IBa or ANG II-induced vasoconstriction. A: pericytes were held at Ϫ100 mV and depolarized to Ϫ10 mV for 300 ms at 10-s intervals. Concatenated responses before (baseline), during (calciseptine), and after (washout) introduction of calciseptine (10 nM) are shown. B: basal (n ϭ 6) and FPL (10 M, n ϭ 9)-stimulated peak IBa using protocol described in A. Calciseptine was without effect. NS, not significant. C: percent reduction of luminal diameter vs. time in microperfused DVR exposed to abluminal ANG II (1 nM) followed by addition and removal of calciseptine (30 nM). Calciseptine failed to reverse ANG IIinduced vasoconstriction. Fig. 9 . Inhibition of IBa-and ANG II-induced vasoconstriction by mibefradil. A: peak IBa in pericytes held at Ϫ90 mV and depolarized to test potentials (Vm) in 10 mM Ba 2ϩ . Inward currents are shown at baseline, in mibefradil (1 M, n ϭ 7), and after washout. Mibefradil was without effect. B: microperfused DVR were exposed to abluminal ANG II followed by addition and removal of mibefradil at 0 M (sham exchange, n ϭ 6), 1 M (n ϭ 6), or 10 M (n ϭ 5). *P Ͻ 0.05 vs. sham exchange. glomerular arterioles (27, 31) , we performed the present study of signature Ca V currents in DVR pericytes. Our initial studies revealed a surprising voltage-gated Na ϩ (Na V ) conductance (32, 58) . Ca V currents, under the conditions used in those studies, were too small to measure. Here, we revised the experimental protocols to enhance the divalent currents, enabling examination of their properties.
In a first series of experiments, we used the dihydropyridine agonist FPL to increase conductance of putative L-type Ca V . FPL elicited small, but detectable, inward current when 1 mM extracellular Ca 2ϩ was the charge carrier ( Fig. 1) . The slow inactivation, threshold for activation near Ϫ40 mV (Fig. 2) , and high conductance to Ba 2ϩ over Ca 2ϩ is consistent with L-type channel behavior (17, 51) . Thus the FPL-based studies strongly support Ca V 1.x expression in DVR pericytes but do not rule out conductance by other isoforms.
In an effort to study Ca V currents in the absence of agonist stimulation, we altered the experimental regimen to increase their magnitude. Since some classes of Ca V are inhibited by Ca 2ϩ , we employed BAPTA in place of EGTA to achieve rapid chelation in the vicinity of the channel pore (46) . Additionally, we increased the concentration of the extracellular charge carrier from 1 to 10 mM. Those changes yielded the desired effect, such that basal Ba 2ϩ and Ca 2ϩ currents became readily detectable (Fig. 6 ). L-type currents peak much later than voltage-gated Na ϩ currents (Fig. 3Aa) , so that there is little risk of an error in quantifying Ca V and Na V currents when both are present. In contrast, T-type currents typically activate and deactivate more quickly, leading us to use TTX to block Na V when quantifying basal Ca V currents of the pericytes. In the absence of FPL, the voltage dependence of the currents shifted by about ϩ10 mV, i.e., stronger depolarizations (to Ϫ30 vs. Ϫ40 mV in FPL; cf. Fig. 5A with Fig. 6A ) were needed to activate the channels. That threshold is more consistent with an L-than a T-type current, which typically activates at lower potentials (56) . For specific contrast, the results in Fig. 6 , can be compared with the elegant studies of Gordienko et al. (Figs. 7 and 8 in Ref. 18 ) in which low-and high-threshold T-and L-type currents coexist in isolated preglomerular smooth muscle cells. As discussed above, much other evidence favoring roles for T-type channels has been obtained through pharmacological inhibition of vasoconstriction and immunostaining (13, 15, 22, 26, 28, 31, 47) . Evidence that basal DVR pericyte currents are also largely conducted by Ca V 1.x, L-type channels is provided by their near elimination with nifedipine and diltiazem (Fig. 7) and twofold greater conductance to Ba 2ϩ over Ca 2ϩ (Fig. 6A) . The open probability of Ca V is determined by a balance of states in which the channels can be opened in response to elevation of membrane potential and inactivation in which the channels cannot respond. Electrophysiologically, that is controlled by holding cells at low potential to remove inactivation and then rapidly shifting to higher potentials to achieve activation; subsequently, closure to the inactivated state occurs spontaneously to limit Ca 2ϩ conductance. The range of membrane potentials at which channels can activate without becoming fully inactivated defines the physiological range for function, i.e., the window current. As shown in Figs. 2B and 6C, the window current lies between Ϫ40 and ϩ10 mV for basal Ca 2ϩ and Ba 2ϩ conductance but is shifted toward more negative values (by ϳ10 mV) in the presence of FPL. Our prior examination of resting membrane potentials in DVR pericytes and its depolarization in response to agonists (ANG II and endothelin) has shown a shift from Ϫ50 to Ϫ70 mV to Ϫ40 to Ϫ20 mV, within the window current range defined here (4, 44) .
We extended our studies by testing the effects of other classical Ca V blockers, calciseptine, mibefradil, and -agatoxin IVA. Calciseptine is a toxin derived from the black Fig. 10 . Lack of effect of -agatoxin IVA to reverse IBa. A: pericytes were held at Ϫ100 mV and depolarized to Ϫ10 mV for 300 ms at 10-s intervals. Concatenated responses before (vehicle) and during and after introduction of -agatoxin IVA are shown. B: peak inward IBa using the protocol described in A with -agatoxin IVA at 20 nM (n ϭ 9) or 100 nM (n ϭ 10). -Agatoxin IVA was without effect. mamba that purportedly blocks L-over T-or N-type channels (39, 56) . Despite the high sensitivity of isolated rabbit arterioles to calciseptine (22, 56) , in a separate series of experiments, we could not demonstrate blockade of FPL-stimulated or unstimulated (basal) Ba 2ϩ currents with that agent (Fig. 8, A  and B) . Calciseptine also failed to reverse ANG II-induced vasoconstriction, mitigating against an effect attributable to ruptured-patch methods (Fig. 8C) . Given the otherwise strong evidence for L-type channels in this preparation (Figs. 1-7) , we speculate that a calciseptine-insensitive Ca V 1.x splice variant exists in the renal medulla of the rat, possibly conferring some resistance to snake venoms. At 1 M, mibefradil failed to block Ba 2ϩ currents or ANG II-induced vasoconstriction (Fig.  9) , providing evidence against T-type currents contaminating the results of prior protocols (Fig. 6 ) and also against participation of T-type channels in ANG II-induced vasoconstriction. At 10 M, mibefradil dilated microperfused DVR, but that may well be attributable to L-type channel blockade at that concentration. Finally, despite the description of their expression in medullary vascular bundles, P/Q-type channel blockade with -agatoxin IVA failed to affect depolarization-induced inward Ba 2ϩ currents (Fig. 10) . We recognize that the failure to observe signature T-or P/Q-type currents does not rule out participation of such channels in DVR vasoactivity under other physiological conditions. Those channels may be present, but they may be dormant because of posttranslational modifications, internalization, or other inhibitory signaling processes that we have yet to define.
GRANTS
Studies in our laboratory were supported by National Institutes of Health Grants DK-42495, DK-67621, and HL-68686.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the authors.
